Published: 11 August 2014
Author(s): Daniela Concolino, Emilia Degennaro, Rossella Parini, on behalf of the Fabry Delphi working group

Management of Anderson–Fabry disease (AFD) is contentious, particularly regarding enzyme replacement therapy (ERT). We report results of a Delphi consensus panel on AFD management.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.